ATE473762T1 - Ein impfstoff - Google Patents
Ein impfstoffInfo
- Publication number
- ATE473762T1 ATE473762T1 AT06809961T AT06809961T ATE473762T1 AT E473762 T1 ATE473762 T1 AT E473762T1 AT 06809961 T AT06809961 T AT 06809961T AT 06809961 T AT06809961 T AT 06809961T AT E473762 T1 ATE473762 T1 AT E473762T1
- Authority
- AT
- Austria
- Prior art keywords
- hsp
- antigenic
- antigenic molecule
- covalently
- vaccine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/255—Salmonella (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN2648DE2005 | 2005-10-04 | ||
| IN2650DE2005 | 2005-10-04 | ||
| PCT/IN2006/000396 WO2007039917A1 (en) | 2005-10-04 | 2006-10-04 | A vaccine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE473762T1 true ATE473762T1 (de) | 2010-07-15 |
Family
ID=37546799
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06809961T ATE473762T1 (de) | 2005-10-04 | 2006-10-04 | Ein impfstoff |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US8241645B2 (de) |
| EP (1) | EP1931389B1 (de) |
| AT (1) | ATE473762T1 (de) |
| DE (1) | DE602006015491D1 (de) |
| WO (1) | WO2007039917A1 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3329935A1 (de) | 2013-08-24 | 2018-06-06 | Bharat Biotech International Limited | Bakterieller impfstoff und verfahren zur herstellung davon |
| CN103995126B (zh) * | 2014-04-18 | 2015-10-14 | 中国农业大学 | 一种检测鸡白痢沙门氏菌抗体的elisa试剂盒 |
-
2006
- 2006-10-04 DE DE602006015491T patent/DE602006015491D1/de active Active
- 2006-10-04 WO PCT/IN2006/000396 patent/WO2007039917A1/en active Application Filing
- 2006-10-04 AT AT06809961T patent/ATE473762T1/de not_active IP Right Cessation
- 2006-10-04 US US11/992,932 patent/US8241645B2/en active Active
- 2006-10-04 EP EP06809961A patent/EP1931389B1/de active Active
Also Published As
| Publication number | Publication date |
|---|---|
| DE602006015491D1 (de) | 2010-08-26 |
| WO2007039917A1 (en) | 2007-04-12 |
| US20100196416A1 (en) | 2010-08-05 |
| EP1931389A1 (de) | 2008-06-18 |
| US8241645B2 (en) | 2012-08-14 |
| EP1931389B1 (de) | 2010-07-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1118492T1 (el) | Φαρμακοτεχνικες μορφες εμβολιου norovirus | |
| CY1123299T1 (el) | Ανοσοενισχυτικη μηνιγκιτιδοκοκκικη πρωτεϊνη προσδεσης παραγοντα η | |
| ATE539767T1 (de) | Adjuvans auf basis von polyinosinsäure/polycytidylsäure | |
| EA202192390A1 (ru) | Биоконъюгаты полисахаридных о-антигенов e.coli, способы их получения и способы их применения | |
| RU2017104529A (ru) | Композиции neisseria meningitidis и способы их применения | |
| JP2014503172A5 (de) | ||
| JP2007538044A5 (de) | ||
| WO2014009438A3 (en) | Mycobacterial antigen vaccine | |
| CY1107390T1 (el) | Εμβολιο εναντι αντιγονων απο βακτηριδια | |
| NO20083062L (no) | Humane monoklonale antistoffer mot fukosyl-GM1 og fremgangsmater for anvendelse av anti-fukosyl-GM1 | |
| NO20062044L (no) | Piscirickettsia salmonis-antigener og anvendelse derav | |
| WO2012051211A3 (en) | Antigen delivery platforms | |
| CL2013000019A1 (es) | Proteina fijadora de antigeno aislada que fija el factor de crecimiento epidermico fijador de heparina (hg-egf); molecula de acido nucleico que la codifica; vector; celula huesped; metodo de preparacion; composicion farmaceutica que la comprende; y su uso para tratar una enfermedad hiperproliferativa. | |
| NO20091665L (no) | Tumorassosierte antigenderivater fra MAGE-familien, og nuklinsyresekvenser som koder for disse, anvendt for fremstilling av fusjonsproteiner og for vaksinesammensetninger | |
| WO2007016185A3 (en) | Mono-and bi-functional antibody conjugates as effective adjuvants of protein vaccination | |
| DE602008000891D1 (de) | Neuartige Formulierungen von Tumor-assoziierten Peptiden, welche an menschliche Leukozytenantigene der Klasse I oder II für Impfungen binden | |
| BR0314373A (pt) | Produto imunogênico estável para a indução de anticorpos contra uma ou várias proteìnas antigênicas em um indivìduo, composições farmacêutica, imunogênica e de vacina e processo de preparação de um produto imunogênico | |
| EA200900738A1 (ru) | Слитые белки, содержащие антигены отторжения опухоли ny-eso-1 и lage-1 | |
| WO2009077577A3 (en) | Vaccine antigens from piscirickettsia salmonis | |
| SE0201701D0 (sv) | Treatment of epithelial tumors and infections | |
| CR9269A (es) | Vacunas orales para peces | |
| WO2000025722A3 (en) | ENHANCED VACCINES COMPRISING SELF AND NON-SELF IgE PORTIONS OR DIMERIC ANTIGENS | |
| WO2010040847A3 (en) | Recombinant protein bodies as immunogen-specific adjuvants | |
| ATE473762T1 (de) | Ein impfstoff | |
| US20180161425A1 (en) | Novel protein structure used for efficient antibody production in immunization |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |